On March 12, 2018, Stock Gumshoe posted an article entitled, “‘Greatest Medical Breakthrough in History’ from Paul Mampilly”. This article goes on to talk about information from Paul Mampilly, who is the author of the Profits Unlimited newsletter published by Banyan Hill. In this article, Mampilly talks about a medical company that is leading the industry right now. Visit stockgumshoe.com to know more.
He claims that it may be more important than any medication, vaccine, or medical device ever created.
Right now, Paul Mampilly is only releasing teasers for his upcoming article, “Greatest Medical Breakthrough in History”. Some of the hints he has released detail that a mid-Western medical company is responsible for the breakthrough and that it is a $1.5 billion company. The phrase “precision medicine” comes up a lot. It is speculated that the company Paul Mampilly is referring to is Myriad Genetics from Utah. Myriad Genetics is known for being a diagnostics company that sells tests to check for the presence of cancer. Myriad offers a variety of tests in order for people to determine if they have certain genetic risk factors for deadly diseases such as breast cancer or colon cancer.
The article goes on to detail Myriad Genetic’s stocks and how their stock prices have rose tremendously in the past few years. In fact, their stock rose from $1.5 billion to $2.2 billion over the past few months. Read more about Paul Mampilly at Ideamensch.
Paul Mampilly is an author at Banyan Hill.
Currently, he is the senior editor of Profits Unlimited, True Momentum, and Extreme Fortunes, all of which are published through Banyan Hill. He graduated from Fordham University in 1996 with an MBA. He also formed Capuchin Consulting and considers himself a proven investment expert. Mampilly also once worked with Kinetics International Fund. Paul Mampilly has been featured on various national news networks for his genius knowledge of money and investments.